Feed GELS
GE
Gelteq Limited Ordinary Shares
GELS · NASDAQ
$0.58 -5.09% (-$0.03)
1M -1.36%
Market Cap $7.5M
P/E Ratio -
Div. Yield -
ROE 40.30%
Valuation
50 /100
Fair P/S 45.57x
P/B 0.48x
P/E N/A
Growth
31 /100
Declining Rev. growth 3.93%
Book val. growth 8.83%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 100.00%
FCF margin 3,721.12%
Net margin 4,011.86%
Quality
0 /100
Poor ROIC 27.41%
Asset turnover 0.01x
ROE 40.30%
Debt
46 /100
Moderate Debt/Equity 0.27x
Int. coverage -2.51x
Current ratio 0.27x
Stability
33 /100
Unstable Beta -0.43x
Profitable years 0
Rev. volatility N/A
Întreabă StockBot despre GELS
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Nathan Jacob Givoni
Employees
18
Headquarters
Clayton